B of A Securities Reinstates Buy on Bank of New York Mellon, Announces $56 Price Target

B of A Securities analyst Ebrahim Poonawala reinstates Bank of New York Mellon (NYSE:BK) with a Buy and announces $56 price target.

byBenzinga Newsdesk

January 12, 2023

1 minute read

B of A Securities analyst Ebrahim Poonawala reinstates Bank of New York Mellon (NYSE:BK) with a Buy and announces $56 price target.

JP Morgan Upgrades Juniper Networks to Overweight, Lowers Price Target to $36

By Benzinga Newsdesk

Today, 2:44 AM

JP Morgan analyst Samik Chatterjee upgrades Juniper Networks (NYSE:JNPR) from Neutral to Overweight and lowers the price target from $37 to $36.

JNPR

Chart Industries Q3 Adj. EPS $1.49 Beats $1.35 Estimate, Sales $412.10M Miss $449.97M Estimate

By Benzinga Newsdesk

Today, 2:44 AM

Chart Industries (NYSE:GTLS) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.35 by 10.37 percent. This is a 69.32 percent increase over earnings of $0.88 per share from the

GTLS

This Multibagger Semiconductor Stock Has Sharp Upside Despite Capex Headwinds and US Embargo, Analyst Writes

By Anusuya Lahiri

Today, 2:44 AM

Benchmark analyst Mark Miller reiterated a Buy on ACM Research, Inc (NASDAQ:ACMR) and a $43 price target. ACM Research (Shanghai), Inc posted preliminary…

ACMR

Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2022; EPS $0.33 Vs $0.25 YoY; Revenues Of $30.3M Vs $28.9M YoY

By Happy Mohamed

Today, 2:44 AM

Revenue Consolidated revenues for fiscal 2022 were $30.3 million compared to $28.9 million for fiscal 2021. The revenues for fiscal 2022 consisted of $29.8 million in processing and storage

CCEL

B of A Securities Reinstates Buy on Bank of New York Mellon, Announces $56 Price Target

Related Posts

JP Morgan Upgrades Juniper Networks to Overweight, Lowers Price Target to $36

Chart Industries Q3 Adj. EPS $1.49 Beats $1.35 Estimate, Sales $412.10M Miss $449.97M Estimate

This Multibagger Semiconductor Stock Has Sharp Upside Despite Capex Headwinds and US Embargo, Analyst Writes

Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2022; EPS $0.33 Vs $0.25 YoY; Revenues Of $30.3M Vs $28.9M YoY